Susquehanna International Group, LLP Kal Vista Pharmaceuticals, Inc. Put Options Transaction History

Susquehanna International Group, LLP

6 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q3 2024 Nov 14, 2024	SELL	$9.46 - $15.39 $40,678 - $66,177	-4,300 Reduced 25.9%	12,300 $142,000
Q2 2024 Aug 15, 2024	SELL	$10.35 - $12.49 $261,855 - $315,997	-25,300 Reduced 60.38%	16,600 $195,000
Q1 2024 May 07, 2024	SELL	$11.07 - $16.04 $398,520 - $577,440	-36,000 Reduced 46.21%	41,900 $496,000
Q4 2023 Feb 14, 2024	BUY	$7.58 - $12.25 $183,436 - $296,450	24,200 Added 45.07%	77,900 $954,000
Q3 2023 Nov 14, 2023	SELL	$8.95 - $11.35 $472,559 - $599,280	-52,800 Reduced 49.58%	53,700 $517,000
Q2 2023 Aug 11, 2023	BUY	$7.73 - $10.57 $823,245 - $1.13 Million	106,500 New	106,500 $958,000

125

47.8M

551K

110K

Ticker KALV
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 24,602,000
Market Cap $229M
Description
KalVista Pharmaceuticals, Inc., a clinical stage pharmaceutical company, discovers, develops, and commercializes small molecule protease inhibitors for diseases with unmet needs. The company's product portfolio comprises small molecule plasma kallikrein inhibitors targeting hereditary angioedema (HAE) and diabetic macular edema (DME); and oral p...

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

Stay updated on Susquehanna International Group, LLP with notifications on news.